Smad7 Controls Resistance of Colitogenic T Cells to Regulatory T Cell-Mediated Suppression

Gastroenterology

Volumn 136, Issue 4, 2009, Pages

  Fantini, Massimo C ^a   Rizzo, Angelamaria ^a   Fina, Daniele ^a   Caruso, Roberta ^a   Sarra, Massimiliano ^a   Stolfi, Carmine ^a   Becker, Christoph ^b   MacDonald, Thomas T ^c   Pallone, Francesco ^a   Neurath, Markus F ^b   Monteleone, Giovanni ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 6; RAG1 PROTEIN; SMAD7 PROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; COLITIS; CONTROLLED STUDY; ENTERITIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; LAMINA PROPRIA; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 62949223226     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.12.053     Document Type: Article

References (36)

1. Bennett C.L., Christie J., Ramsdell F., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27 (2001) 20-21
2. Brunkow M.E., Jeffery E.W., Hjerrild K.A., et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27 (2001) 68-73
3. Wildin R.S., Ramsdell F., Peake J., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27 (2001) 18-20
4. Powrie F., Leach M.W., Mauze S., et al. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol 5 (1993) 1461-1471
5. Mottet C., Uhlig H.H., and Powrie F. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 170 (2003) 3939-3943
6. Huber S., Schramm C., Lehr H.A., et al. Cutting edge: TGF-β signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells. J Immunol 173 (2004) 6526-6531
7. Maul J., Loddenkemper C., Mundt P., et al. Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology 128 (2005) 1868-1878
8. Makita S., Kanai T., Oshima S., et al. CD4+CD25 bright T cells in human intestinal lamina propria as regulatory cells. J Immunol 173 (2004) 3119-3130
9. Kelsen J., Agnholt J., Hoffmann H.J., et al. FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease. Clin Exp Immunol 141 (2005) 549-557
10. Nakamura K., Kitani A., Fuss I., et al. TGF-β 1 plays an important role in the mechanism of CD4+CD25+ regulatory T-cell activity in both humans and mice. J Immunol 172 (2004) 834-842
11. Maloy K.J., Salaun L., Cahill R., et al. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 197 (2003) 111-119
12. Fahlen L., Read S., Gorelik L., et al. T cells that cannot respond to TGF-β escape control by CD4(+)CD25(+) regulatory T cells. J Exp Med 201 (2005) 737-746
13. Li M.O., Wan Y.Y., and Flavell R.A. T cell-produced transforming growth factor-β1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26 (2007) 579-591
14. Monteleone G., Kumberova A., Croft N.M., et al. Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel disease. J Clin Invest 108 (2001) 601-609
15. Boirivant M., Pallone F., Di Giacinto C., et al. Inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-β1-mediated suppression of colitis. Gastroenterology 131 (2006) 1786-1798
16. Dominitzki S., Fantini M.C., Neufert C., et al. Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells. J Immunol 179 (2007) 2041-2045
17. Fantini M.C., Rizzo A., Fina D., et al. IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells. Eur J Immunol 37 (2007) 3155-3163
18. Fantini M.C., Becker C., Tubbe I., et al. Transforming growth factor β induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis. Gut 55 (2006) 671-680
19. Asseman C., Read S., and Powrie F. Colitogenic Th1 cells are present in the antigen-experienced T-cell pool in normal mice: control by CD4+ regulatory T cells and IL-10. J Immunol 171 (2003) 971-978
20. Kehrl J.H., Wakefield L.M., Roberts A.B., et al. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T-cell growth. J Exp Med 163 (1986) 1037-1050
21. Mangan P.R., Harrington L.E., O'Quinn D.B., et al. Transforming growth factor-β induces development of the T(H)17 lineage. Nature 441 (2006) 231-234
22. Bettelli E., Carrier Y., Gao W., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 (2006) 235-238
23. Peluso I., Fantini M.C., Fina D., et al. IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes. J Immunol 178 (2007) 732-739
24. Comes A., Rosso O., Orengo A.M., et al. CD25+ regulatory T-cell depletion augments immunotherapy of micrometastases by an IL-21-secreting cellular vaccine. J Immunol 176 (2006) 1750-1758
25. Li M.O., Sanjabi S., and Flavell R.A. Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25 (2006) 455-471
26. Gorelik L., and Flavell R.A. Abrogation of TGFβ signaling in T cells leads to spontaneous T-cell differentiation and autoimmune disease. Immunity 12 (2000) 171-181
27. Nakao A., Miike S., Hatano M., et al. Blockade of transforming growth factor β/Smad signaling in T cells by overexpression of Smad7 enhances antigen-induced airway inflammation and airway reactivity. J Exp Med 192 (2000) 151-158
28. Derynck R., and Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 425 (2003) 577-584
29. Kim B.G., Li C., Qiao W., et al. Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature 441 (2006) 1015-1019
30. Neurath M.F., Weigmann B., Finotto S., et al. The transcription factor T-bet regulates mucosal T-cell activation in experimental colitis and Crohn's disease. J Exp Med 195 (2002) 1129-1143
31. Gorelik L., Constant S., and Flavell R.A. Mechanism of transforming growth factor beta-induced inhibition of T-helper type 1 differentiation. J Exp Med 195 (2002) 1499-1505
32. Manel N., Unutmaz D., and Littman D.R. The differentiation of human T(H)-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt. Nat Immunol 9 (2008) 641-649
33. Curotto de Lafaille M.A., Lino A.C., Kutchukhidze N., et al. CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion. J Immunol 173 (2004) 7259-7268
34. Izcue A., Hue S., Buonocore S., et al. Interleukin-23 restrains regulatory T-cell activity to drive T cell-dependent colitis. Immunity 28 (2008) 559-570
35. Chen W., Jin W., Hardegen N., et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med 198 (2003) 1875-1886
36. Fantini M.C., Becker C., Monteleone G., et al. Cutting edge: TGF-β induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 172 (2004) 5149-5153